Colgate-Palmolive
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Colgate-Palmolive (India) is strategically pivoting towards a premiumization-led growth model, as highlighted by management's focus on brand equity and category expansion. This approach is expected to drive revenue growth, particularly in the under-penetrated premium segments, despite facing competitive pressures in niche markets. The company's recent performance indicates a recovery in revenue, with a projected 9% CAGR through FY28, supported by increased advertising expenditures aimed at enhancing market share. Vista's financial outlook reflects this optimism, forecasting stable margins and a fair valuation aligned with intrinsic value, with an expected upside of approximately 18%. However, the company must navigate rising input costs and competitive pricing pressures that could challenge margin expansion. The FMCG sector's growth, driven by e-commerce and favorable macroeconomic conditions, further supports Colgate's outlook. Over the next 12-24 months, key opportunities include leveraging digital channels and expanding the premium product portfolio, while watchpoints include the impact of inflation on consumer spending and the need for sustained volume growth amidst heightened competition
Why We Like This Stock
- Management's focus on premiumization is expected to drive significant revenue growth in under-penetrated segments
- Increased investment in advertising and digital channels is enhancing market share and brand equity
- The FMCG sector's expansion and recovery in consumer demand provide a favorable backdrop for Colgate's growth strategy
Things To Watch Out For
- Rising input costs and competitive pricing pressures may limit margin expansion
- Potential risks from inflation could impact consumer spending, particularly in rural markets
- Execution risks related to sustaining volume growth amidst heightened competition remain a concern
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 5,680 | 6,040 | 6,035 | 6,393 | 6,860 |
| Profit Before Tax (Cr.) | 1,801 | 1,930 | 1,809 | 1,878 | 2,060 |
| PBT Margin | 31.7% | 32.0% | 30.0% | 29.4% | 30.0% |
| Net Profit (Cr.) | 1,302 | 1,434 | 1,327 | 1,373 | 1,506 |
| Earnings Per Share | 47.9 | 52.7 | 48.8 | 50.5 | 55.4 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| JPMorgan | ► Neutral | 1,976 | 17-Sep-2026 |
| Axis Securities | ▲ Buy | 1,889 | 18-Aug-2026 |
| Citigroup | ▼ Sell | 2,000 | 18-Aug-2026 |
| Goldman Sachs | ▼ Sell | 2,050 | 18-Aug-2026 |
| HSBC | ► Hold | 2,140 | 18-Aug-2026 |
| Jeffries | ▲ Buy | 2,650 | 18-Aug-2026 |
| Prabhudas Liladhar | ► Hold | 2,242 | 18-Aug-2026 |
| Motilal Oswal | ▲ Buy | 2,500 | 17-Aug-2026 |
| Emkay Global | ▼ Reduce | 2,050 | 30-Jul-2026 |
| HDFC Securities | ▼ Reduce | 2,000 | 30-Jul-2026 |
| ICICI Securities | ► Hold | 2,250 | 30-Jul-2026 |
| Kotak Securities | ▼ Sell | 2,075 | 30-Jul-2026 |
| Moneycontrol | ► Equalweight | nan | 30-Jul-2026 |
| Nomura | ▲ Buy | 2,550 | 30-Jul-2026 |
| BofA | ▼ Sell | 2,055 | 09-Jul-2026 |
Company Overview
Show Company Profile
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, serum, rinses, whitening products, hand washes, and shower gels under the Colgate and Palmolive brand name. It also offers soaps, cosmetics, and toiletries. In addition, the company exports its products. Colgate-Palmolive (India) Limited was incorporated in 1937 and is headquartered in Mumbai, India.